Clinical Trial Update: Botox Versus Tacrolimus in Psoriasis Vulgaris [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing Botox (onabotulinumtoxinA) with tacrolimus for psoriasis vulgaris is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Assiut University | Conditions: Psoriasis Vulgaris | Phase 4 | Status: NOT_YET_RECRUITING